Working Paper |
File Downloads |
Abstract Views |
Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
Aging and the Growth of Long-Term Care |
0 |
0 |
0 |
29 |
0 |
0 |
1 |
134 |
Aging and the Growth of Long-Term Care |
0 |
0 |
0 |
242 |
0 |
0 |
1 |
1,286 |
An Economic Evaluation of the War on Cancer |
0 |
0 |
1 |
96 |
0 |
0 |
3 |
355 |
Are the Young Becoming More Disabled? |
0 |
0 |
0 |
93 |
0 |
0 |
0 |
344 |
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer |
0 |
0 |
0 |
152 |
0 |
0 |
3 |
540 |
Does Medicare Benefit the Poor? New Answers to an Old Question |
0 |
0 |
0 |
67 |
0 |
1 |
2 |
376 |
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? |
0 |
0 |
0 |
23 |
0 |
0 |
1 |
35 |
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? |
0 |
0 |
0 |
85 |
0 |
0 |
2 |
33 |
Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey |
0 |
0 |
1 |
55 |
9 |
16 |
44 |
237 |
Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn? |
0 |
0 |
0 |
5 |
0 |
1 |
3 |
30 |
Effects of expanding health screening on treatment – What should we expect? What can we learn? |
0 |
0 |
1 |
6 |
0 |
1 |
3 |
50 |
Evaluation of Medical Technologies with Uncertain Benefits |
0 |
0 |
0 |
48 |
0 |
0 |
3 |
41 |
Food Prices and the Dynamics of Body Weight |
0 |
0 |
0 |
70 |
0 |
0 |
2 |
229 |
HIV Breakthroughs and Risk Sexual Behavior |
0 |
0 |
0 |
84 |
0 |
4 |
5 |
633 |
Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses |
0 |
0 |
0 |
13 |
0 |
0 |
1 |
50 |
Health Insurance as a Two-Part Pricing Contract |
0 |
0 |
0 |
97 |
0 |
0 |
1 |
421 |
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data |
0 |
0 |
0 |
52 |
0 |
0 |
1 |
189 |
Insurance and Innovation in Health Care Markets |
0 |
0 |
0 |
136 |
0 |
0 |
0 |
465 |
Insurance, Self-Protection, and the Economics of Terrorism |
0 |
0 |
0 |
287 |
0 |
0 |
0 |
884 |
Insurer Bargaining and Negotiated Drug Prices in Medicare Part D |
0 |
0 |
0 |
32 |
0 |
0 |
3 |
145 |
Insurers' Negotiating Leverage and the External Effects of Medicare Part D |
0 |
0 |
0 |
14 |
0 |
0 |
0 |
95 |
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
69 |
Intellectual Property and Marketing |
0 |
0 |
0 |
91 |
0 |
0 |
5 |
384 |
International Differences in Longevity and Health and Their Economic Consequences |
0 |
0 |
0 |
35 |
0 |
0 |
0 |
122 |
International Differences in Longevity and Health and their Economic Consequences |
0 |
0 |
0 |
51 |
2 |
2 |
4 |
261 |
International Differences in Longevity and Health and their Economic Consequences |
0 |
0 |
0 |
54 |
0 |
0 |
0 |
167 |
Mortality Risk, Insurance, and the Value of Life |
0 |
0 |
1 |
37 |
1 |
1 |
5 |
43 |
Nonprofit Production |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
195 |
Nonprofit Production and Competition |
2 |
2 |
3 |
296 |
2 |
3 |
7 |
1,236 |
Optimal Liability for Terrorism |
0 |
0 |
0 |
40 |
0 |
0 |
2 |
211 |
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D |
0 |
0 |
1 |
22 |
1 |
5 |
11 |
89 |
The Declining Quality of Teachers |
0 |
0 |
1 |
221 |
0 |
1 |
5 |
1,670 |
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination |
0 |
0 |
4 |
490 |
0 |
1 |
17 |
1,594 |
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination |
0 |
0 |
1 |
88 |
0 |
0 |
4 |
364 |
The Insurance Value of Medical Innovation |
0 |
0 |
1 |
31 |
0 |
0 |
2 |
95 |
The Rise in Old Age Longevity and the Market for Long-Term Care |
0 |
0 |
0 |
233 |
0 |
1 |
2 |
1,767 |
The Value of Medican and Pharmaceutical Interventions for Reducing Obesity |
0 |
0 |
1 |
29 |
0 |
2 |
5 |
161 |
The Welfare Effects of Medical Malpractice Liability |
0 |
0 |
0 |
101 |
0 |
1 |
3 |
462 |
The Welfare Effects of Public Drug Insurance |
0 |
0 |
0 |
77 |
0 |
0 |
0 |
284 |
Time-Inconsistency and Welfare |
0 |
0 |
0 |
78 |
0 |
2 |
4 |
371 |
Understanding Health Disparities Across Education Groups |
0 |
0 |
0 |
390 |
0 |
0 |
4 |
1,681 |
Understanding the Economic Consequences of Shifting Trends in Population Health |
0 |
0 |
0 |
42 |
0 |
0 |
0 |
222 |
Understanding the Economic Consequences of Shifting Trends in Population Health |
0 |
0 |
0 |
36 |
0 |
0 |
0 |
111 |
Understanding the Economic Consequences of Shifting Trends in Population Health |
0 |
0 |
0 |
50 |
0 |
0 |
0 |
177 |
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market |
0 |
0 |
0 |
15 |
2 |
3 |
10 |
96 |
Vaccine Allocation Priorities Using Disease Surveillance and Economic Data |
0 |
0 |
2 |
2 |
0 |
0 |
9 |
13 |
Total Working Papers |
2 |
2 |
18 |
4,198 |
17 |
45 |
180 |
18,417 |